HRT Financial
IPSC icon

HRT Financial’s Century Therapeutics IPSC Stock Holding History

HRT Financial’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27K Buy
+11,267
New +$25.7K ﹤0.01% 3890
2025
Q4 		– Sell
-18,113
Closed -$9K – 3578
2025
Q3 		$9K Sell
18,113
-92,951
-84% -$50.1K ﹤0.01% 2754
2025
Q2 		$62K Buy
+111,064
New +$59.6K ﹤0.01% 2279
2024
Q1 		– Sell
-17,528
Closed -$58K – 2668
2023
Q4 		$58K Buy
+17,528
New +$31.9K ﹤0.01% 1943

Other funds holding IPSC

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

HRT Financial's IPSC Position: Q2 2026 in Review

HRT Financial opened a new position in Century Therapeutics (IPSC) in Q2 2026: 11,267 shares worth $27K. The stake represents ﹤0.01% of the portfolio and ranks #3890 among its holdings. This is a return to the name: HRT Financial previously reported a position in IPSC as recently as Q3 2025.

HRT Financial first reported a position in IPSC in Q4 2023 and has held it in 4 quarters since. The position peaked at $62K in Q2 2025. 100 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • HRT Financial held 11,267 shares of Century Therapeutics worth $27K as of Q2 2026.
  • Century Therapeutics was a new HRT Financial position in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3890 holding.
  • HRT Financial first reported a position in Century Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • HRT Financial's Century Therapeutics position peaked at $62K in Q2 2025.
  • 100 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.